Clinical trials show patients lost an average of 15% body weight, and some lost up to 20%
At 24 weeks, the 10 mg and 15 mg tirzepatide groups also spent more time in the target range compared to the insulin group
Too slow and you spend months at doses too low to activate the GLP-1 and GIP receptors that make tirzepatide effective in the first place
Overall, most clients receive their medication within 8-10 business days from when they speak to their provider
Human Clinical Data To date, large-scale clinical trials involving thousands of human participants, such as the SURPASS and SURMOUNT clinical trial programs , have not shown a definitive link between tirzepatide and thyroid cancer in humans
You might qualify if you meet one of these main criteria: A body mass index (BMI) of 30 kg/m or higher A BMI of 27 kg/m or higher with at least one weight-related health condition Health conditions that support your eligibility include: High blood pressure Type 2 diabetes High cholesterol Heart disease Sleep apnea The FDA expanded semaglutides approval in March 2024
